Pharma
Stay updated with the latest happenings in the pharmaceutical industry. Get insights into drug development, innovations, regulatory updates, and emerging trends. Discover the advancements shaping the future of healthcare. Explore the world of pharma with our comprehensive coverage at Pharmtales.com.
Breaking: Biogen announces a massive layoff of 1,000 employees
Biogen, a pharmaceutical company, is undergoing a fresh wave of layoffs, with a targeted reduction of 1,000 positions following last ...
Bayer Takes Swift Action with $500,000 Aid Package for Maui After Devastating Wildfires
Responding promptly to the aftermath of the destructive wildfires on Maui, pharmaceutical giant Bayer is stepping up as one of ...
Seagen’s Tukysa Demonstrates Trial Victory in Breast Cancer, Amplifying Roche’s Kadcyla and Significance in Light of Pfizer’s $43B Acquisition
In a strategic move, Pfizer has announced a hefty investment of $43 billion to acquire Seagen, with a keen focus ...
Nine States Pushback Against Lilly’s $13.5M Insulin Pricing Settlement
In a dramatic legal showdown, nine states are raising objections to a potentially game-changing $13.5 million settlement that pharmaceutical giant ...
MikeWorldWide Unveils MWW Health, a Novel Healthcare Venture Spearheaded by Matter Health’s Ryan Lilly
In a strategic move to augment their healthcare offerings, MikeWorldWide is introducing a pioneering healthcare endeavor known as MWW Health. ...
FDA Grants Approval to Ipsen’s Sohonos Capsules, the First-Ever Treatment for Individuals with Fibrodysplasia Ossificans Progressiva
In 2019, Ipsen made a significant investment of $1 billion to acquire Clementia Pharmaceuticals and its rare disease drug, palovarotene. ...
Keytruda Gets Green Light from NHS for New Cancer ‘Basket’
MSD’s Keytruda (pembrolizumab) has secured a significant recommendation from the UK’s National Institute for Health and Care Excellence (NICE), signaling ...
Abortion Pill Restrictions Upheld by Federal Appeals Court
US Federal Appeals Court Partially Supports Limits on Access to Medical Abortion Pill, Setting Stage for Possible Supreme Court Decision. ...
Boehringer’s Obesity Drug with Dual Mechanism Ready for Phase III
Boehringer Ingelheim is forging ahead with its obesity drug candidate, survodutide, moving it into a Phase III program following promising ...
Abcuro’s KLRG1 Drug Gets $155M Boost for Clinical Trials
Abcuro Secures Impressive $155 Million in Oversubscribed Funding Round to Propel Clinical Trials of ABC008, a Groundbreaking Drug for Inclusion ...
GSK’s Arexvy Takes Lead in RSV Vaccine Race, Now Accessible at Leading US Pharmacies
In the competitive landscape of the respiratory syncytial virus (RSV) vaccine market, GlaxoSmithKline (GSK) stands out with its well-timed strides. ...
Nobel Prize Winner’s Biotech Company Escapes the Graveyard with SPAC
Reviving a Silent Spell: Celixir, a UK-based cell therapy biotech, emerges from the shadows with a transformative move. Following a ...
Ad Council and Alzheimer’s Association’s Fresh Push to Raise Alzheimer’s Awareness in Hispanic Community
The Ad Council and the Alzheimer’s Association (AA) have unveiled a poignant new slogan, “Some Things Come with Age,” designed ...
Teva Gains Trial Postponement for Unique Appeal Strategy in Copaxone Case Against US Government
After an enduring three-year legal battle against allegations by the US government, Teva Pharmaceuticals has managed to secure a delay ...
Carvykti CAR-T Therapy by J&J and Legend Biotech Persists Amid New Bispecific
Johnson & Johnson and Legend Biotech’s Carvykti maintains growth in the multiple myeloma market despite the emergence of a more ...
Chiesi Teams Up with Aliada to Advance Brain-Penetrating Therapies for Central Nervous System Disorders
Chiesi Pharma, a specialist in rare diseases, has entered into a strategic collaboration with US biotech company Aliada Therapeutics. The ...
Chimerix’s ONC201 Shows Promise Against H3K27M-Mutant Gliomas
Chimerix, a biopharmaceutical company committed to enhancing and extending the lives of patients grappling with severe diseases, has unveiled significant ...
CSL Benefits from Strong Top-Line Growth Due to Surge in Plasma Collections Post-Pandemic
The challenges faced by CSL during the pandemic’s lockdown, primarily reliant on plasma collection, were to be expected. However, a ...
Sanofi Fails to Secure Reata in Bidding Battle Against Biogen Following Horizon Setback
Biogen’s pursuit of Reata, a rare disease company based in Texas, has unveiled a compelling narrative of corporate rivalry and ...
Department of Justice Criticises Chamber of Commerce’s Lawsuit Against IRA’s Medicare Price Negotiations
Exactly one year has passed since President Joe Biden’s signature inked the Inflation Reduction Act (IRA) into law. In a ...
Prescription Drug Cost Concerns Escalate to Shared ‘Core Value’ Across Party Lines, Survey Finds
Mounting worries over the soaring costs of prescription drugs have transcended political boundaries to become a deeply entrenched concern among ...
FDA Issues Warning Letter to AstraZeneca Regarding ‘Misleading’ Breztri Efficacy Claims
AstraZeneca’s promotional campaign for Breztri Aerosphere, a treatment for chronic obstructive pulmonary disease (COPD), has encountered significant regulatory turbulence, with ...
Humira Biosimilars: Benefits, Availability, Price, Comparison and More
In this article, we will give you an overview of Humira biosimilars, including their benefits, availability, prices, and how they ...
Biogen Outbids Competitor in $7.3 Billion Reata Pharmaceuticals Acquisition Duel
In a surprising turn of events, Biogen’s acquisition of Reata Pharmaceuticals for $7.3 billion raised eyebrows among industry observers last ...
Delcath Triumphs After Years: FDA Grants Approval to Hepzato Kit for Treating Metastatic Uveal Melanoma
After enduring nearly a decade of setbacks, Delcath has finally achieved a regulatory milestone in the United States. Delaware-based Delcath ...
COVID-19 Vaccine Makers Prepare for Private-Market Launches Amid Evolving Variants
Following a decline in demand for COVID-19 vaccines, prominent biopharmaceutical companies are gearing up for private-market launches this upcoming fall. ...
Regeneron Faces New Challenges as Biosimilars Target Eylea Market Dominance, Novartis’ Sandoz Takes Aim with Therapeutic Equivalence
Regeneron finds itself at a crossroads as its blockbuster eye drug Eylea contends with an FDA rejection and growing competition ...
Novo Nordisk and Eli Lilly Ride Obesity and Diabetes Drugs to the Forefront in Q2 Pharmaceutical Performance
As the COVID-19 pandemic surged and waned, the biopharmaceutical industry witnessed a rollercoaster ride of revenue spikes and troughs. However, ...
Amgen Takes a Playful Approach with Otezla Advertisement Amid Growing Competition in the Psoriasis Market
Amgen, a major biotech company, has taken an innovative approach to connect with psoriasis patients by using humor in their ...
Japanese Government Backs Arcalis with $115 Million Grants for mRNA Vaccine Production
Following Daiichi Sankyo’s recent accomplishment of securing Japan’s first mRNA vaccine approval, a potential competitor has emerged backed by significant ...
